Stay updated on Eli Lilly and Company Press Releases

Sign up to get notified when there's something new on the Eli Lilly and Company Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Eli Lilly and Company Press Releases page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now foregrounds new investor and product/clinical program updates (Bernstein Forum participation, Brain Health Matters with Julianne Moore, TuneLab AI platform, Orforglipron and Jaypirca BRUIN CLL-313 results) and removes older messaging such as U.S. leadership branding, the Court Is Hers campaign, and prior Q2 results.
    Difference
    100%
    Check dated 2025-09-12T00:25:53.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now includes a significant update regarding Lilly's olomorasib, which has received the U.S. FDA's Breakthrough Therapy designation for treating certain lung cancers, while previous content about Mounjaro's cardiovascular benefits has been removed.
    Difference
    28%
    Check dated 2025-09-04T21:51:48.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The webpage has added significant information regarding Lilly's Verzenio and orforglipron, highlighting their efficacy in treating breast cancer and obesity, respectively. Additionally, details about upcoming healthcare conferences featuring Lilly executives have been included.
    Difference
    100%
    Check dated 2025-08-28T16:03:49.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Anne White will retire as Executive Vice President and President of Lilly Neuroscience effective December 31, 2025, marking a significant leadership change at Eli Lilly. Additionally, the company has reiterated its commitment to maintaining the U.S. as a leader in biopharmaceutical innovation.
    Difference
    100%
    Check dated 2025-08-21T12:53:50.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Eli Lilly has launched a new initiative called 'The Court Is Hers™' to promote youth basketball for girls in Indianapolis, and reported significant financial growth in Q2 2025, raising its revenue guidance. However, several previous FDA approvals related to Alzheimer's treatments have been removed from the page.
    Difference
    100%
    Check dated 2025-08-14T09:20:48.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The webpage has removed significant press release content regarding Eli Lilly's product approvals, financial announcements, and clinical trial results, which are crucial for stakeholders and investors. Additionally, there are new cookie consent options introduced.
    Difference
    100%
    Check dated 2025-08-07T07:18:25.000Z thumbnail image

Stay in the know with updates to Eli Lilly and Company Press Releases

Enter your email address, and we'll notify you when there's something new on the Eli Lilly and Company Press Releases page.